Through new methods of the molecular medicine, a previously unknown wealth of detail on our own biology has been opened. This high level of detail allows innovative treatments and a greater individualization of medicine. At the same time, this previously unknown data provides new approaches to the analysis of diseases and their causes, and, at the same time, new ways to address the problems of handling, interpreting and using this data.
From 1- 2 July 2015, the German National Academy of Sciences Leopoldina and Hasso Plattner Institute presented the international symposium “Big Data in Medicine” at the HPI campus in Potsdam. The objective of this symposium was to support the exchange of scientists in different areas, to identify approaches for the implementation of Big Data in foundational biomedical research, individualized medicine and clinical practice and to discuss solutions to existing problems.